Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Medical Industry Feature

Navigating Systemic Therapy Eligibility and Treatment Goals in Psoriasis Care

Details
Recommended

Overview

ReachMD Healthcare Image
RestartResume

Hear about criteria for determining systemic therapy eligibility in psoriasis patients with a focus on special area involvement.

Take Post-Survey

If you’ve already completed the activity.

  • Sponsored by

  • Overview

    In 2019, the International Psoriasis Council expanded the eligibility criteria for systemic treatment in psoriasis patients,1,2 allowing clinicians to identify more patients eligible for systemic therapy, avoid treatment delays, and ultimately improve quality of life.1 In light of this criteria update, Dr. James Song and Ms. Lakshi Marie Aldredge sit down with Dr. Charles Turck to share their perspectives on optimizing psoriasis assessment and navigating systemic therapy selection. Dr. Song is the Director of Clinical Research and Co-Chief Medical Officer at Frontier Dermatology in Mill Creek, Washington, and Ms. Aldredge is the Director of the Primary Care NP Residency Program at the VA Portland Healthcare System in Portland, Oregon.

    References:

    1. Strober B, Ryan C, van de Kerkhof P, et al. Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council. J Am Acad Dermatol. 2020;82(1):117-122.
    2. Golbari NM, van der Walt JM, Blauvelt A, Ryan C, van de Kerkhof P, Kimball AB. Psoriasis severity: commonly used clinical thresholds may not adequately convey patient impact. J Eur Acad Dermatol Venereol. 2021;35:417-421.

    ABBV-US-01887-MC Version 1.0 January 2025

Schedule19 Feb 2025